Remember Lucira Health's 30 Minute Home Test Kit? Pfizer Just Bought the Bankrupt Company Via Winning Auction Bid
Remember Lucira Health's 30 Minute Home Test Kit? Pfizer Just Bought the Bankrupt Company Via Winning Auction Bid
Lucira Health Inc (OTC:LHDXQ) has been acquired by Pfizer Inc (NYSE:PFE) for $36.4 million through a bankruptcy auction. According to the SEC document, the asset sale closed on April 20.
露西拉健康公司 （OTC: LHDXQ）已被收购 辉瑞公司 纽约证券交易所代码：PFE）通过破产拍卖以3640万美元的价格出售。根据 秒 文件，资产出售于4月20日结束。
The company filed for bankruptcy in February, just two days before receiving FDA Emergency Use Authorization for the first over-the-counter (OTC) at-home diagnostic test to differentiate and detect influenza A and B.
该公司在二月份申请破产，就在获得美国食品药品管理局紧急使用授权的前两天，首次用于区分和检测甲型和乙型流感的非处方（OTC）家庭诊断测试
COVID-19 & Flu Home Test is a single-use at-home test kit that provides results from self-collected nasal swab samples in roughly 30 minutes.
COVID-19 & Flu Home Test 是一款一次性家用测试套件，可在大约 30 分钟内提供自采鼻拭子样本的结果。
In the SEC filing, it said Pfizer entered the winning bid in an April 6 auction for Lucira's assets.
在美国证券交易委员会的文件中，该公司表示，辉瑞在4月6日对卢西拉资产的拍卖中中标。
Lucira Health snowballed over the past several years amid the COVID-19 pandemic. Demand for the company's COVID-19 test kits surged, and it posted positive net income in its 2022 first quarter for the first time since its inception.
在过去的几年中，在 COVID-19 疫情期间，Lucira Health 的规模激增。对该公司 COVID-19 测试套件的需求激增，该公司自成立以来首次在 2022 年第一季度公布正净收入。
Also Read: FDA's Regulatory Delay is The Reason For Novavax, Lucira Health's Failure: WSJ Report.
另请阅读：《华尔街日报》报道，美国食品药品管理局的监管延迟是Novavax、Lucira Health失败的原因。
During filing for Chapter 11, the company said a protracted EUA process for its COVID-19 and influenza test had been costly without new revenue from the combined test kit during the 2022-2023 flu season.
在申请第 11 章时，该公司表示，在 2022-2023 年流感季节，如果联合检测试剂盒没有新的收入，EUA 的 COVID-19 和流感测试过程旷日持久，成本高昂。
FDA officials responded to the statements about a perceived lengthy EUA process, saying it had found Lucira's COVID-19 and flu test had contained a toxic substance in one of the test components.
美国食品药品管理局官员对有关欧盟程序可能漫长的声明做出了回应，称发现卢西拉的 COVID-19 和流感测试在其中一个测试成分中含有有毒物质。
Price Action: PFE shares are up 0.18% at $38.81 on the last check Friday.
价格走势： 在周五的最后一张支票中，PFE股价上涨了0.18％，至38.81美元。